Our investors include international investment banks, pension funds, development funds, academic institutions, strategic corporate investors and high net worth individuals.

We commit capital across the UK and are headquartered in Cambridge, UK, at the centre of one of the world's fastest growing technology clusters. We are also represented on the East Coast of the USA.

We have made three or four investments in new companies each year since the closure of our fund in early 2000. In addition we also make a number of follow-on investments each year in companies that are already part of the Cambridge Gateway Fund portfolio.

The Fund is advised by Avlar BioVentures Ltd, which is authorised and regulated by the Financial Services Authority.